Enhanced tumor inhibiting effect of 131I-BDI-1-based radioimmunotherapy and cytosine deaminase gene therapy modulated by a radio-sensitive promoter in nude mice bearing bladder cancer

Radioimmunotherapy (RIT) has great potential in cancer therapy. However, its efficacy in numerous tumors is restricted due to myelotoxicity, thereby limiting the dose of radionuclide. To increase tumor radiosensitivity, we incorporated the recombinant lentivirus into the EJ cells (bladder cancer [BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Pan, Zhang, Chunli, Ma, Huan, Wang, Rongfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855308/
https://www.ncbi.nlm.nih.gov/pubmed/36418230
http://dx.doi.org/10.1093/jrr/rrac075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855308/
https://www.ncbi.nlm.nih.gov/pubmed/36418230
http://dx.doi.org/10.1093/jrr/rrac075

Ejemplares similares